Astrazeneca (AZN) Cash from Investing Activities Growth (1y) (2010 - 2026)
Analysis
Astrazeneca (AZN) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.04 Bn | 602.06 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 362.64 Bn | 362.64 Bn | - | - |
| 3 | General Electric | 329.87 Bn | 320.52 Bn | 6.95 Bn | -71.66% |
| 4 | Astrazeneca | 253.67 Bn | 248.39 Bn | 12.86 Bn | -38.14% |
| 5 | Citigroup | 228.64 Bn | -2,073.66 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.08 Bn | 197.54 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - | - |
| 9 | Unilever | 139.34 Bn | 132.31 Bn | - | - |
| 10 | Hdfc Bank | 117.87 Bn | 80.72 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.14% |
| Mar 31, 2026 | -43.02% |
| Dec 31, 2025 | -22.44% |
| Sep 30, 2025 | -32.17% |
| Jun 30, 2025 | 26.60% |
| Mar 31, 2025 | 48.07% |
| Jun 30, 2024 | -452.31% |
| Mar 31, 2024 | -93.66% |
| Jun 30, 2023 | 35.00% |
| Mar 31, 2023 | -641.67% |
| Jun 30, 2022 | -238.98% |
| Mar 31, 2022 | -130.27% |
| Dec 31, 2021 | -761.59% |
| Sep 30, 2021 | -1,704.14% |
| Jun 30, 2021 | -259.46% |
| Mar 31, 2021 | 6,066.67% |
| Dec 31, 2020 | 1,871.43% |
| Sep 30, 2020 | -883.78% |
| Jun 30, 2020 | 113.25% |
| Mar 31, 2020 | -97.26% |